{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:07:27Z","timestamp":1761822447908},"reference-count":23,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>An 11-year-old boy with hemoglobin sickle disease (HbSD), bilateral stenosis of the intracranial carotid arteries, and moyamoya syndrome had recurrent ischemic strokes with aphasia and right hemiparesis. His parents (Jehovah's Witnesses) refused blood transfusions. After bilateral extracranial\u2013intracranial (EC-IC) bypass surgery, hydroxyurea treatment increased hemoglobin F (HbF) levels to more than 30%. During a follow-up of 28 months, flow velocities in the basal cerebral arteries remained stable, neurologic sequelae regressed, and ischemic events did not recur. This is the first report of successful hydroxyurea treatment after bypass surgery for intracranial cerebral artery obstruction with moyamoya syndrome in sickle cell disease. The patient's religious background contributed to an ethically challenging therapeutic task.<\/jats:p>","DOI":"10.1182\/blood.v97.7.2165","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"2165-2167","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Stroke in hemoglobin (SD) sickle cell disease with moyamoya: successful hydroxyurea treatment after cerebrovascular bypass surgery"],"prefix":"10.1182","volume":"97","author":[{"given":"Markus","family":"Schmugge","sequence":"first","affiliation":[{"name":"From the Departments of Hematology and Neurology, University Children's Hospital, Zu\u0308rich; and the Departments of Neurosurgery, Neurology, and Pediatrics\/Hematology-Oncology Unit, University Hospital, Geneva, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Frischknecht","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Neurology, University Children's Hospital, Zu\u0308rich; and the Departments of Neurosurgery, Neurology, and Pediatrics\/Hematology-Oncology Unit, University Hospital, Geneva, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Yonekawa","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Neurology, University Children's Hospital, Zu\u0308rich; and the Departments of Neurosurgery, Neurology, and Pediatrics\/Hematology-Oncology Unit, University Hospital, Geneva, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf W.","family":"Baumgartner","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Neurology, University Children's Hospital, Zu\u0308rich; and the Departments of Neurosurgery, Neurology, and Pediatrics\/Hematology-Oncology Unit, University Hospital, Geneva, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Boltshauser","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Neurology, University Children's Hospital, Zu\u0308rich; and the Departments of Neurosurgery, Neurology, and Pediatrics\/Hematology-Oncology Unit, University Hospital, Geneva, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Humbert","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Neurology, University Children's Hospital, Zu\u0308rich; and the Departments of Neurosurgery, Neurology, and Pediatrics\/Hematology-Oncology Unit, University Hospital, Geneva, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021216560088900_B1","first-page":"708","article-title":"Hemoglobin SD disease.","volume":"141","author":"Laws","year":"1993","journal-title":"Monatsschr Kinderheilkd."},{"key":"2020021216560088900_B2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00127893-199901000-00004","article-title":"Moyamoya disease status, 1998.","volume":"5","author":"Yonekawa","year":"1999","journal-title":"Neurologist."},{"key":"2020021216560088900_B3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0022-3476(78)81086-5","article-title":"Moyamoya in children with sickle cell anemia and cerebrovascular occlusion.","volume":"93","author":"Seeler","year":"1978","journal-title":"J Pediatr."},{"key":"2020021216560088900_B4","first-page":"465","article-title":"Cerebrovascular complications of sickle-cell anemia.","volume":"144","author":"Vernant","year":"1988","journal-title":"Rev Neurol."},{"key":"2020021216560088900_B5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0887-8994(96)00045-8","article-title":"Encephaloduroarteriosynangiosis in a child with sickle cell anaemia and moyamoya disease.","volume":"14","author":"Vernet","year":"1996","journal-title":"Pediatr Neurol."},{"key":"2020021216560088900_B6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0303-8467(97)00038-3","article-title":"Midwest experience with moyamoya disease.","volume":"99(suppl 2)","author":"Edwards-Brown","year":"1997","journal-title":"Clin Neurol Neurosurg."},{"key":"2020021216560088900_B7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0303-8467(97)00039-5","article-title":"Risk factors of moyamoya disease in Canada and the USA.","volume":"99(suppl 2)","author":"Peerless","year":"1997","journal-title":"Clin Neurol Neurosurg."},{"key":"2020021216560088900_B8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/01616412.1997.11740774","article-title":"EC-IC bypass improves chronic ischemia in a patient with moyamoya disease secondary to sickle cell disease: an in vivo microdialysis study.","volume":"19","author":"Mendelowitsch","year":"1997","journal-title":"Neurol Res."},{"key":"2020021216560088900_B9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1365-2141.2000.01912.x","article-title":"Management of cerebral vasculopathy in children with sickle cell anaemia.","volume":"108","author":"Powars","year":"2000","journal-title":"Br J Haematol."},{"key":"2020021216560088900_B10","first-page":"213","article-title":"Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.","volume":"28","author":"Ohene-Frempong","year":"1991","journal-title":"Semin Hematol."},{"key":"2020021216560088900_B11","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors.","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood."},{"key":"2020021216560088900_B12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.","volume":"339","author":"Adams","year":"1992","journal-title":"N Engl J Med."},{"key":"2020021216560088900_B13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease.","volume":"340","author":"Steinberg","year":"1999","journal-title":"N Engl J Med."},{"key":"2020021216560088900_B14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V63.1.162.162","article-title":"Effect of transfusion therapy on arteriographic abnormalities and on the recurrence of stroke in sickle cell disease.","volume":"63","author":"Russell","year":"1984","journal-title":"Blood."},{"key":"2020021216560088900_B15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3171\/jns.2000.93.3.0397","article-title":"Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease.","volume":"93","author":"Kawaguchi","year":"2000","journal-title":"J Neurosurg."},{"key":"2020021216560088900_B16","first-page":"50","article-title":"Direct and combined revascularisation in pediatric moyamoya disease.","volume":"45","author":"Golby","year":"1999","journal-title":"Neurosurgery"},{"key":"2020021216560088900_B17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia: investigators of the multicenter study of hydroxyurea in sickle cell anemia.","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med."},{"key":"2020021216560088900_B18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00043426-199707000-00009","article-title":"Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease: the French study group on sickle cell disease.","volume":"19","author":"de Montalembert","year":"1997","journal-title":"J Pediatr Hematol Oncol."},{"key":"2020021216560088900_B19","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood.V88.6.1960.bloodjournal8861960","article-title":"Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial.","volume":"88","author":"Ferster","year":"1996","journal-title":"Blood."},{"key":"2020021216560088900_B20","first-page":"1848a","article-title":"Hydroxyurea is safe and effective in 2 to 5 year old children with sickle cell disease [abstract].","volume":"94(suppl 1)","author":"Hoppe","year":"1999","journal-title":"Blood."},{"key":"2020021216560088900_B21","first-page":"2861a","article-title":"A two-year pilot trial of hydroxyurea in very young children with sickle cell disease [abstract].","volume":"94(suppl 1)","author":"Wang","year":"1999","journal-title":"Blood."},{"key":"2020021216560088900_B22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ajh.2830500211","article-title":"Hydroxyurea: an alternative to transfusion therapy for stroke in sickle cell anemia.","volume":"50","author":"Ware","year":"1995","journal-title":"Am J Hematol."},{"issue":"suppl 1","key":"2020021216560088900_B23","first-page":"1845a","article-title":"Progressive pulmonary hypertension and pulmonary insufficiency in sickle cell patients who respond to hydroxyurea [abstract].","volume":"94","author":"Sutton","year":"1999","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/7\/2165\/1671798\/h8070102165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/7\/2165\/1671798\/h8070102165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T22:28:17Z","timestamp":1581546497000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/97\/7\/2165\/53348\/Stroke-in-hemoglobin-SD-sickle-cell-disease-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,1]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v97.7.2165","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,4,1]]}}}